Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04327141 · ClinicalTrials.gov registry record · NA

Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women

A NA study of Weight Loss and Gut Microbiome, sponsored by Skidmore College.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04327141: Active NA study of Weight Loss and Gut Microbiome, sponsored by Skidmore College.

NCT04327141 is a NA study of Weight Loss and Gut Microbiome that is active but no longer recruiting, run by Skidmore College. The registered enrollment target is 40 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04327141, a NA study of Weight Loss and Gut Microbiome, is active but no longer recruiting, sponsored by Skidmore College.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study will systematically quantify the effects of protein pacing and intermittent fasting (P-IF) on total and regional (abdominal) body composition (lean mass and fat mass), blood glucose and lipids, and anti-aging biomarkers, hunger ratings, and the gut microbiome in 40 overweight/obese adult men (n=20) and women (n=20) following a 8-week weight loss intervention. Participants will be enrolled in the study as a single cohort and participate in a 8-week weight loss (WL) trial consisting of a single dietary intervention phase. The purpose of the additional 12 month follow up case study (in addition to the initial 12-month case study period) is to scientifically document a significant weight loss and improved body composition following combined protein pacing intermittent fasting nutrition and a safe, effective exercise program in a study participant who achieved successful weight loss maintenance during the previous 12 month follow up study period.

Interventions

  • BEHAVIORAL P-IF
  • BEHAVIORAL HH

Study Locations (1)

New York

  • Human Nutrition and Metabolism Laboratory - Saratoga Springs

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-09-03
Est. Completion 2024-12-31
Phase NA
Skidmore College

13 total trials

What the registry record for NCT04327141 still lists

NCT04327141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which P-IF is the first listed.

NCT04327141 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04327141 about?

NCT04327141 is a clinical study titled "Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women". This study will systematically quantify the effects of protein pacing and intermittent fasting (P-IF) on total and regional (abdominal) body composition (lean mass and fat mass), blood glucose and lipids, and anti-aging biomarkers, hunger ratings, and the gut microbiome in 40 overweight/obese adult ...

What is the current status of trial NCT04327141?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-09-03. Estimated completion is 2024-12-31.

What conditions does trial NCT04327141 study?

This clinical trial studies the following conditions: Weight Loss, Gut Microbiome, Anti Aging.

What interventions are being tested in trial NCT04327141?

The interventions under investigation include: P-IF (BEHAVIORAL), HH (BEHAVIORAL).

Who is sponsoring clinical trial NCT04327141?

This trial is sponsored by Skidmore College, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04327141 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04327141's enrollment target sits among peer trials

40 87th of 116 higher than 26 of 116 other Weight Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04327141, the US trial registry maintained by the National Library of Medicine. NCT04327141 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.